compounded semaglutide fda news The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA Warns Against Using Compounded

The tissue is identifiable, the injection can be placed in proximity, and BPC-157s direct activation of tendon fibroblasts and local angiogenesis addresses the biological bottleneck precisely

It's gut patients in general

Chart: Intuitive Surgical year-over-year bariatric procedure growth

The one human trial that will measure tolerability directly has not started reporting it is only recruiting (planned 2026), studies a topical gel on small standardized wounds , and lists safety as a secondary, not primary, outcome (NCT07437586)

Melanotan II has been researched extensively for use in protecting against the harmful effects of ultraviolet radiation from sunlight due to its melanogenesis-stimulating properties